Skip to main content
Tech.euFundingExplorerBeta

Gray’s Creek Capital Partners

Investor profile

Private equity

Gray’s Creek Capital Partners has backed 1 European tech company across 1 funding round in 2021, joining rounds totalling €95M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2021
1 yr
Total round €
€95M
sum of rounds joined

Deals by year

distinct rounds / year
Gray’s Creek Capital Partners — deals by year — interactive chart.
Data table
Gray’s Creek Capital Partners — deals by year
20211

Top sectors

by deals
Gray’s Creek Capital Partners — top sectors — interactive chart.
Data table
Gray’s Creek Capital Partners — top sectors
Healthtech1

Stages

by deals
Gray’s Creek Capital Partners — stages — interactive chart.
Data table
Gray’s Creek Capital Partners — stages
Other1

Countries

by deals
Gray’s Creek Capital Partners — countries — interactive chart.
Data table
Gray’s Creek Capital Partners — countries
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Gray’s Creek Capital Partners — 1 dealsGray’s Creek Capital PartnersAdage Capital Management — 1 shared deals · click to openAdage Capital ManagementCureDuchenne Ventures — 1 shared deals · click to openCureDuchenne VenturesDeerfield — 1 shared deals · click to openDeerfieldLaurion Capital Management — 1 shared deals · click to openLaurion Capital ManagementOxford Sciences Innovation — 1 shared deals · click to openOxford Sciences InnovationRA Capital Management — 1 shared deals · click to openRA Capital ManagementSamsara Biocapital — 1 shared deals · click to openSamsara BiocapitalTudor Investment Corporation — 1 shared deals · click to openTudor Investment CorporationViking Global Investors — 1 shared deals · click to openViking Global Investors

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
PepgenUK1€95M

Biggest deals

top 10 by amount
CompanyStageAmountDate
PepgenOther€95M2021-08
← Back to investors